Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Indomethacin × Clear all

NCT02935205 2023-11-29

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

Phase 1/2 Unknown

Prostatic Neoplasms